<DOC>
	<DOCNO>NCT00825942</DOCNO>
	<brief_summary>To determine safety initial efficacy C-KAD ophthalmic solution patient asteroid hyalosis</brief_summary>
	<brief_title>An Open-Label Study Effect Ophthalmic Solution Asteroid Hyalosis</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Presence asteroid hyalosis Active ocular infection Glaucoma Ocular hypertension Ocular inflammatory disorder</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Asteroid hyalosis</keyword>
	<keyword>Opthalmic Study</keyword>
</DOC>